Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at : ckbsupport@jax.org

NCT ID NCT03567720
Title Tavo and Pembrolizumab With or Without Chemotherapy in Patients With Inoperable Locally Advanced or Metastatic TNBC
Recruitment Active, not recruiting
Gender both
Phase Phase II
Variant Requirements Yes
Sponsors OncoSec Medical Incorporated
Indications
Therapies
Age Groups: adult | senior
Covered Countries USA | AUS

Facility Status City State Zip Country Details
University of Arizona Tucson Arizona 85719 United States Details
UC San Diego La Jolla California 92093 United States Details
Stanford University Medical Center Palo Alto California 94304 United States Details
The Lundquist Institute Torrance California 90502 United States Details
University of Colorado Cancer Center Aurora Colorado 80045 United States Details
Moffitt Cancer Center Tampa Florida 33612 United States Details
University of Chicago Chicago Illinois 60637 United States Details
University Hospitals Seidman Cancer Center Cleveland Ohio 44106 United States Details
Virginia Cancer Specialists Fairfax Virginia 22031 United States Details
University of Washington, Seattle Cancer Care Alliance Seattle Washington 98195 United States Details
Westmead Hospital Westmead New South Wales 2145 Australia Details
Princess Alexandra Hospital Woolloongabba Queensland 4102 Australia Details
Calvary Central Districts Hospital Elizabeth Vale South Australia 5112 Australia Details
Box Hill Hospital Box Hill Victoria 3128 Australia Details
*Shaded cells indicate that there was no data available from clincialtrials.gov for the field